Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28244105 | 0.78 | — | — | |
| SCHEMBL17696695 | 0.78 | — | — | |
| SCHEMBL6576156 | 0.78 | — | — | |
| SCHEMBL17923493 | 0.76 | — | — | |
| SCHEMBL5426167 | 0.75 | — | — | |
| SCHEMBL28384976 | 0.74 | — | — | |
| SCHEMBL17061029 | 0.71 | — | — | |
| SCHEMBL748440 | 0.71 | — | — | |
| SCHEMBL331834 | 0.71 | — | — | |
| Ethyl Chloride SCHEMBL10612356 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0653439-B1 | Stabilized oligonucleotids and the use thereof | AVENTIS PHARMA GMBH (DE) | 2004-04-28 | — | — | EP | claimed |
| US-6348312-B1 | OLIGONUCLEOTIDE HAVING LENGTH OF 6-100 NUCLEOTIDES, WHEREIN AT LEAST ONE NON-TERMINAL PYRIMIDINE NUCLEOSIDE IS MODIFIED, AND ALSO 5' AND/OR 3' ENDS ARE MODIFIED, BY REPLACEMENT OF 3' AND/OR 5' PHOSPHODIESTER BRIDGE BY PHOSPHOROTHIOATE BRIDGE | HOESCHT AKTIENGESELLSCHAFT (DE) | 2002-02-19 | — | — | US | disclosed |